KODAMA Fumio | Department of Chemotherapy, Kanagawa Cancer Center
スポンサーリンク
概要
関連著者
-
KODAMA Fumio
Department of Chemotherapy, Kanagawa Cancer Center
-
Kodama Fumio
Department Of Chemotherapy Kanagawa Cancer Center
-
Tomita Naoto
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Tomit Naoto
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
KANAMORI Heiwa
Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of
-
ISHIGATSUBO Yoshiaki
Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of
-
MARUTA Atsuo
Department of Hematology, Kanagawa Cancer Center
-
Kanamori Heiwa
Department Of Hematology Kanagawa Cancer Center
-
Kanamori Heiwa
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
OKUBO Takao
First Department of Internal Medicine, Yokohama City University
-
TOMITA Naoto
Department of Hematology, Yokohama City University Medical Center
-
MOTOMURA Shigeki
Department of Chemotherapy, Kanagawa Cancer Center
-
Ishigatsubo Yoshiaki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Maruta Atsuo
Department Of Hematology Kanagawa Cancer Center
-
Maruta A
Kanagawa Cancer Center Yokohama City Jpn
-
KOHARAZAWA Hideyuki
the First Department of Internal Medicine, Yokohama City University School of Medicine
-
Koharazawa Hideyuki
The First Department Of Internal Medicine Yokohama City University School Of Medicine
-
Okubo Takao
Kumamoto Daiichi Hospital
-
Okubo Takao
First Department Of Internal Medicine Yokohama City University
-
Tomita Naoto
Department Of Hematology Graduate School Of Medicine Yokohama City University
-
Kodama F
東大 先端経済工学研セ
-
Kodama Fumio
Department Of Hematology And Chemotherapy Kanagawa Cancer Center
-
Mohri H
The First Department Of Internal Medicine Yokohama City University School Of Medicine
-
KOHARAZAWA Hideyuki
Department of Hematology and Chemotherapy, Kanagawa Cancer Center
-
HATTORI Michiko
Department of Hematology and Chemotherapy, Kanagawa Cancer Center
-
Kuwabara Hideyuki
Department Of Hematology Kanagawa Cancer Center
-
Motomura Shigeki
Department Of Hematology Yokohama City University Medical Center
-
Ishigatsubo Yoshiaki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
MOTOMURA Shigeki
First Department of Internal Medicine, Urafune Hospital, Yokohama City University School of Medicine
-
Koharazawa Hideyuki
Department Of Hematology And Chemotherapy Kanagawa Cancer Center
-
Takeuchi Kengo
Department Of Pathology Cancer Institute Japanese Foundation For Cancer Research
-
TAGUCHI Jun
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
FUJITA Hiroyuki
Department of Rheumatology/Hematology/Infectious Disease, Yokohama City University Hospital
-
FUJISAWA Shin
Yokohama City University Medical Center
-
Takeuchi Jin
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
MOTOHASHI Kenji
Department of Hematology, Kanagawa Cancer Center
-
SAKAI Rika
Department of Hematology, Kanagawa Cancer Center
-
FUJISAWA Shin
Department of Hematology, Yokohama City University Medical Center
-
MOHRI Hiroshi
First Department of Internal Medicine, Yokohama City University
-
Takeuchi Kengo
Department Of Laboratory Medicine Research Hospital The Institute Of Medical Science The University
-
FUJITA Atsuko
Department of Hematology, Yokohama City University Medical Center
-
HYO Rie
Department of Hematology, Yokohama City University Medical Center
-
HASHIMOTO Chizuko
Department of Hematology, Yokohama City University Medical Center
-
TAKEMURA Sachiya
Department of Hematology and Immunology, Fujisawa City Hospital
-
YAMAZAKI Etsuko
Department of Hematology and Immunology, Fujisawa City Hospital
-
Motohashi Kenji
Department Of Hematology Kanagawa Cancer Center
-
Motohashi Kenji
Department Of Applied Physics Faculty Of Technology Tokyo University Of Agriculture And Technology
-
Hyo Rie
Department Of Hematology Yokohama City University Medical Center
-
Sakai Rika
Department Of Hematology Kanagawa Cancer Center
-
Yamazaki Etsuko
Department Of Hematology And Immunology Fujisawa City Hospital
-
Mohri Hiroshi
First Department Of Internal Medicine School Of Medicine Yokohama City University
-
Fujita Atsuko
Department Of Hematology Yokohama City University Medical Center
-
Taguchi Jun
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Taguchi Jun
Department Of Hematology Kanagawa Cancer Center
-
TANABE Juichi
Department of Hematology and Chemotherapy, Kanagawa Cancer Center
-
TOMIT Naoto
Department of Haematology/Chemotherapy, Kanagawa Cancer Center
-
Fujita Hiroyuki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Fujita Hiroyuki
Department Of Environmental Immuno-dermatology Yokohama City University Graduate School Of Medicine
-
Hashimoto Chizuko
Department Of Hematology Yokohama City University Medical Center
-
Fujisawa Shin
Department Of Hematology Yokohama City University Medical Center
-
Tanabe Juichi
Department Of Hematology And Chemotherapy Kanagawa Cancer Center
-
Sakai Rika
Department Of Hematology Yokohama City University Medical Center
-
Tomit Naoto
Department Of Haematology/chemotherapy Kanagawa Cancer Center
-
Fujita Hiroyuki
Department Of Hematology Shizuoka Red Cross Hospital
-
Takemura Sachiya
Department Of Hematology And Immunology Fujisawa City Hospital
-
Matsumoto Kenji
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Takeuchi Kengo
Respiratory Disease Center Yokohama City University Medical Center
-
TAGUCHI Jun
Department of Chemistry and Materials Science Tokyo Institute of Technology
著作論文
- Outcome of Involved-Field Radiotherapy for Stage 1 Follicular Lymphoma
- Secondary Central Nervous System Lymphoma
- Allogeneic peripheral blood progenitor cell transplantation conditioned with anti-thymocyte globulin for treatment of graft failure after allogeneic bone marrow transplantation
- Successful treatment of a Jehovah's Witness with Acute promyleocytic leukemia